As new research findings indicate, the number of U.S. cattle deaths linked to Zilmax could reach into the thousands. That's far higher than the figures Merck reported to the FDA,<em> Reuters</em> reports. And it could seriously interfere with Merck's plans to relaunch the $160 million growth-stimulating drug.
written on 13.03.2014